대한핵의학회지 (1967년~2009년)
Nucl Med Mol Imaging 2008;42(5)362~368
아데노신 부하 1시간 지연 Tc-99m tetrofosmin 게이트 심근 SPECT에서 관찰되는 심장 대 폐 섭취비의 임상적 유용성: 관상동맥조영술과의 비교
(The Clinical Efficacy of Lung to Heart Ratio in 1 Hour Delayed Tc-99m Tetrofosmin Gated Myocardial SPECT after Adenosine Stress: Comparison with Coronary Angiography)
Author 원경숙,
Kyoung Sook Won, M.D., Ph.D
Affiliation 계명대학교 의과대학 핵의학교실
Department of Nuclear Medicine, Keimyung University School of Medicine, Daegu, Korea
Abstract

Purpose: It is well known that lung to heart ratio (LHR) is one of the high risk findings in Tl-201 myocardial perfusion SPECT. We evaluated the clinical efficacy of LHR to identify severe coronary artery disease in adenosine stress Tc-99m tetrofosmin gated myocardial perfusion SPECT (gSPECT). Materials and Methods: The study population was 157 patients who underwent both adenosine stress Tc-99m gSPECT and coronary angiography (CAG) within one month. According to the results of CAG and gSPECT LHR and the incidence of increased LHR were compared. Results: Among 53 patients with normal coronary arteries increased LHR was found in 2 patients (3.8%) and 0 in 44 patients (0%) with one vessel disease, 2 in 27 with two vessel disease (7.4%) and 8 in 33 with triple vessel disease (24.2%). Significant differences were found in LHR between subgroups of summed stress score, summed rest score and LV ejection fraction (LVEF). There were weak negative correlation between LHR and LVEF and weak positive correlation between LHR and SSS and SRS. Conclusion: Increased LHR had higher incidence in patients with triple vessel disease, severe LV dysfunction and/or extensive perfusion defect than those of normal group. Although its sensitivity might be low to identify severe coronary artery disease, LHR could be helpful in abnormal myocardial perfusion SPECT to stratify risk and prognosis. (Nucl Med Mol Imaging 2008;42(5):362-368)

Keyword Tc-99m tetrofosmin, SPECT, lung to heart ratio, coronary angiography
Full text Article 450505.pdf 450505.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)